In this study, we demonstrated that specific germline variants in ANGPT/TEK and VEGF/VEGFR genes may predict treatment failure, progression, and prognosis in HNSCC patients after radical RT with or without CHT. The gene discussed is KDR; the disease is head and neck squamous cell carcinoma.